BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36499743)

  • 1. A Single Variant in Pri-miRNA-155 Associated with Susceptibility to Hereditary Breast Cancer Promotes Aggressiveness in Breast Cancer Cells.
    Landeros N; Gonzalez-Hormazabal P; Pérez-Moreno P; Tapia JC; Jara L
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
    Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
    Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
    Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
    Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variation in MicroRNA-423 Promotes Proliferation, Migration, Invasion, and Chemoresistance in Breast Cancer Cells.
    Morales-Pison S; Jara L; Carrasco V; Gutiérrez-Vera C; Reyes JM; Gonzalez-Hormazabal P; Carreño LJ; Tapia JC; Contreras HR
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
    Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
    Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
    Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
    Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration.
    Xiong J; Wei B; Ye Q; Liu W
    Biochem Biophys Res Commun; 2019 Aug; 516(3):1013-1018. PubMed ID: 27003255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
    El Din GS; Youness RA; Assal RA; Gad MZ
    Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
    Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
    Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
    Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
    Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.